¼¼°èÀÇ Áøµå±â ¸Å°³ ³ú¿° ½ÃÀå º¸°í¼­(2025³â)
Tick Borne Encephalitis Global Market Report 2025
»óǰÄÚµå : 1751140
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,160,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,904,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,649,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Áøµå±â ¸Å°³ ³ú¿° ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â¿¡´Â ¿¬Æò±Õ 7.7%ÀÇ CAGR·Î 142¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ¼ºÀåÀº Áøµå±â ¸Å°³ ³ú¿°ÀÇ À¯º´·ü Áõ°¡, ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±Ý Áö¿ø Áõ°¡, ÀϺ»³ú¿° ¹ß»ý·ü Áõ°¡, Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê È®´ë, Áß»êÃþ Áõ°¡ µîÀÇ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ ½Ã±âÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¹é½Å °³¹ßÀÇ ÁøÀü, Áø´Ü ¹× Ä¡·á¹ýÀÇ ±â¼ú Çõ½Å, °¨½Ã ¹× Á¦¾ÐÀ» À§ÇÑ Á¤ºÎÀÇ ³ë·Â, Áúº´ ÀüÆÄ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ȯ°æ º¯È­, °¨¿°º´ Á¦¾ÐÀ» À§ÇÑ Á¤ºÎÀÇ ³ë·Â °­È­ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

±âÈÄ º¯È­ÀÇ ¿µÇâ È®´ë´Â ÇâÈÄ Áøµå±â ¸Å°³ ³ú¿° ½ÃÀåÀÇ È®´ë¸¦ °¡¼ÓÈ­ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âÈĺ¯È­´Â ÁÖ·Î È­¼®¿¬·áÀÇ ¼Òºñ¿Í »ï¸² ¹úä µî Àΰ£ Ȱµ¿¿¡ ÀÇÇØ ¾ß±âµÇ´Â Áö±¸ÀÇ ±â¿Â°ú ±â»ó ÆÐÅÏÀÇ Àå±âÀûÀÎ º¯È­¸¦ ¸»ÇÕ´Ï´Ù. Áö±¸ÀÇ ±â¿Â »ó½ÂÀº È­¼®¿¬·áÀÇ °úµµÇÑ ¿¬¼Ò·Î ÀÎÇÑ Á÷Á¢ÀûÀÎ °á°úÀ̸ç, ÀÌ»êȭź¼Ò, ¸Þź µî ¿Â½Ç°¡½º¸¦ ´ë·®À¸·Î ¹èÃâÇÏ¿© ´ë±â Áß¿¡ ¿­À» °¡µÎ¾î ³õ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¿Â »ó½ÂÀº µû¶æÇÑ È¯°æ°ú ¿ÂÈ­ÇÑ °Ü¿ï·Î ÀÎÇØ Áúº´À» ¸Å°³ÇÏ´Â Áøµå±âÀÇ ¼­½ÄÁö¸¦ ³ÐÇô °¨¿°·ü Áõ°¡¿Í Áø´Ü °Ë»ç, ¹é½Å, Ç×¹ÙÀÌ·¯½º Ä¡·áÁ¦ÀÇ ¼ö¿ä Áõ°¡·Î À̾îÁý´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 11¿ù ¼¼°è±â»ó±â±¸(WMO)´Â ¿¤´Ï´¢ Çö»óÀ¸·Î ÀÎÇÑ ¿Â³­È­ÀÇ ¿µÇâÀ¸·Î 2024³â 1¿ùºÎÅÍ 9¿ù±îÁö ¼¼°è Æò±Õ ±â¿ÂÀÌ »ê¾÷Çõ¸í ÀÌÀü Æò±Õº¸´Ù 1.54¡É ´õ ³ô¾Ò´Ù°í º¸°íÇß½À´Ï´Ù(ºÒÈ®½Ç¼º ¸¶ÁøÀº +-0.13¡É). ±× °á°ú, ÇöÀç ÁøÇà ÁßÀÎ ±âÈĺ¯È­°¡ Áøµå±â ¸Å°³ ³ú¿° ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÇØ¿Ü¿©ÇàÀÇ Áõ°¡´Â Áøµå±â ¸Å°³ ³ú¿° ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇØ¿Ü¿©ÇàÀº °ü±¤, ºñÁî´Ï½º, ±³À°, ÀÌÁÖ µîÀÇ ÀÌÀ¯·Î »ç¶÷µéÀÌ ±¹°æÀ» ³Ñ¾î À̵¿ÇÏ´Â °ÍÀ» Æ÷ÇÔÇÕ´Ï´Ù. °¡Ã³ºÐ ¼ÒµæÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ·¹Àú, ºñÁî´Ï½º, ±³À° ¸ñÀûÀ¸·Î ÇØ¿Ü¿©ÇàÀ» ÇÒ ¼ö ÀÖ´Â ¿©À¯°¡ ÀÖ´Â »ç¶÷µéÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇØ¿Ü¿©ÇàÀÇ Áõ°¡´Â Áøµå±â ¸Å°³ ³ú¿°ÀÇ Ä¡·á ¼ö¿ä¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Áøµå±â ¸Å°³ ³ú¿°ÀÌ À¯ÇàÇÏ´Â Áö¿ªÀ» ¹æ¹®ÇÏ´Â ¿©Çà°´ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °¨¿°µÈ Áøµå±â¿¡ ³ëÃâµÉ ±âȸ°¡ ¸¹¾ÆÁö°í, ¿¹¹æ ¹é½Å Á¢Á¾ ¹× ³ëÃâ ÈÄ Ä¡·áÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö±â ¶§¹®ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2025³â 1¿ù À¯¿£¼¼°è°ü±¤±â±¸(UNWTO)´Â 2024³â¿¡´Â ¾à 14¾ï ¸íÀÌ ±¹Á¦¼± Ç×°øÆíÀ» ÀÌ¿ëÇϰí, 2023³â¿¡ ºñÇØ ±¹Á¦¼± À̿밴ÀÌ 1¾ï 4,000¸¸ ¸í Áõ°¡ÇÏ¿© ÆÒµ¥¹Í ÀÌÀü ¼öÁØ(99%)À¸·Î °ÅÀÇ ¿ÏÀüÈ÷ ȸº¹µÉ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¿©ÇàÀÇ ±ÞÁõÀº Áøµå±â ¸Å°³ ³ú¿° ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Tick-borne encephalitis (TBE) is a viral infection transmitted to humans through the bite of an infected tick, primarily the Ixodes species. The virus targets the central nervous system, leading to brain inflammation (encephalitis). Symptoms can range from mild flu-like signs to severe neurological issues, including fever, headache, confusion, and, in some cases, paralysis or seizures.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main products used for tick-borne encephalitis (TBE) include TBE vaccines, tick repellents, diagnostic tests, and antiviral drugs. TBE vaccines are biological preparations designed to stimulate the immune system to recognize and fight the TBE virus. The virus is caused by several types, including the European tick-borne encephalitis virus, Siberian tick-borne encephalitis virus, and Far Eastern tick-borne encephalitis virus. These vaccines can be administered through parenteral and other routes. They are distributed via both online and offline channels and are used by travelers, outdoor enthusiasts, healthcare providers, and research institutions.

The tick borne encephalitis market research report is one of a series of new reports from The Business Research Company that provides tick borne encephalitis market statistics, including tick borne encephalitis industry global market size, regional shares, competitors with a tick borne encephalitis market share, detailed tick borne encephalitis market segments, market trends and opportunities, and any further data you may need to thrive in the tick borne encephalitis industry. This tick borne encephalitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tick borne encephalitis market size has grown strongly in recent years. It will grow from $9.77 billion in 2024 to $10.56 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth observed in the historic period can be attributed to several factors, including a growing geriatric population, an increasing incidence of tick bites, a rise in the disease's prevalence, and a growing demand for effective and safe vaccines.

The tick borne encephalitis market size is expected to see strong growth in the next few years. It will grow to $14.21 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth projected for the forecast period can be attributed to factors such as the rising prevalence of tick-borne encephalitis, increasing government funding for healthcare facilities, a growing incidence of Japanese encephalitis, expanding government initiatives, and the rising middle class. Key trends during this period include advancements in vaccine development, technological innovations in diagnostics and therapeutics, government initiatives for surveillance and control, environmental changes affecting disease transmission, and enhanced government efforts for infectious disease control.

The growing effects of climate change are expected to accelerate the expansion of the tick-borne encephalitis market in the future. Climate change refers to the long-term changes in global temperature and weather patterns, primarily caused by human activities such as fossil fuel consumption and deforestation. The rise in global temperatures is a direct result of excessive fossil fuel burning, which releases significant amounts of greenhouse gases such as carbon dioxide and methane, trapping heat in the atmosphere. This increase in temperature helps expand the habitats of ticks that carry diseases, due to warmer conditions and milder winters, leading to higher infection rates and an increased demand for diagnostic tests, vaccines, and antiviral treatments. For instance, in November 2024, the World Meteorological Organization (WMO) reported that from January to September 2024, the global mean surface air temperature was 1.54°C above the pre-industrial average (+-0.13°C margin of uncertainty), driven by the warming effects of the El Nino event. Consequently, the ongoing climate change is driving the growth of the tick-borne encephalitis market.

The increase in international travel is anticipated to further boost the growth of the tick-borne encephalitis market. International travel involves the movement of people across borders for reasons such as tourism, business, education, or migration. As disposable income rises, more people are able to afford leisure, business, and educational trips internationally. This rise in international travel contributes to the demand for tick-borne encephalitis treatment, as more travelers visit regions where the disease is endemic, increasing their exposure to infected ticks and the need for preventive vaccinations and medical care following exposure. For example, in January 2025, the United Nations World Tourism Organization reported that an estimated 1.4 billion people traveled internationally in 2024, marking a near-full recovery to pre-pandemic levels (99%), with 140 million more international arrivals compared to 2023. This surge in travel drives the growth of the tick-borne encephalitis market.

The rising government investment in healthcare is expected to accelerate the growth of the tick-borne encephalitis market moving forward. Government funding refers to financial support provided to organizations, projects, or individuals to promote public services, economic development, research, or other policy goals. This increase in funding is primarily due to heightened investments in public health and infrastructure, as governments allocate more resources to bolster healthcare systems, support economic recovery, and boost research and development. Government funding has a positive impact on the tick-borne encephalitis market by supporting vaccination campaigns, expanding immunization efforts in endemic regions, reducing infection rates, and increasing public access to preventive healthcare. For example, in May 2024, a report from the Office for National Statistics indicated that in 2023, the UK government's expenditure accounted for the majority of healthcare financing, totaling $309 billion (£239 billion), or 81.9% of overall healthcare spending. Thus, growing government healthcare funding is driving the growth of the tick-borne encephalitis market.

Major players in the tick borne encephalitis market are Pfizer Inc., Health Mil, Sanofi Pasteur, Novartis AG, GlaxoSmithKline (GSK) Plc, Mayo Clinic, Superdrug Health Clinic, Bavarian Nordic, Passport Health, Valneva SE, Microgen, Travel Doctor-TMVC, DIESSE Diagnostica Senese S.p.A., The Native Antigen Company, Fleet Street Clinic, Progen, Smarta Healthcare, QED Bioscience Inc., Serion Immunologics, Chumakov Federal Scientific Center.

Europe was the largest region in the tick borne encephalitis market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in tick-borne encephalitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tick-borne encephalitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tick-borne encephalitis market consists of sales of immune globulins, protective clothing and tick barriers, and surveillance and monitoring systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tick Borne Encephalitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tick borne encephalitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for tick borne encephalitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tick borne encephalitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Tick Borne Encephalitis Market Characteristics

3. Tick Borne Encephalitis Market Trends And Strategies

4. Tick Borne Encephalitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tick Borne Encephalitis Growth Analysis And Strategic Analysis Framework

6. Tick Borne Encephalitis Market Segmentation

7. Tick Borne Encephalitis Market Regional And Country Analysis

8. Asia-Pacific Tick Borne Encephalitis Market

9. China Tick Borne Encephalitis Market

10. India Tick Borne Encephalitis Market

11. Japan Tick Borne Encephalitis Market

12. Australia Tick Borne Encephalitis Market

13. Indonesia Tick Borne Encephalitis Market

14. South Korea Tick Borne Encephalitis Market

15. Western Europe Tick Borne Encephalitis Market

16. UK Tick Borne Encephalitis Market

17. Germany Tick Borne Encephalitis Market

18. France Tick Borne Encephalitis Market

19. Italy Tick Borne Encephalitis Market

20. Spain Tick Borne Encephalitis Market

21. Eastern Europe Tick Borne Encephalitis Market

22. Russia Tick Borne Encephalitis Market

23. North America Tick Borne Encephalitis Market

24. USA Tick Borne Encephalitis Market

25. Canada Tick Borne Encephalitis Market

26. South America Tick Borne Encephalitis Market

27. Brazil Tick Borne Encephalitis Market

28. Middle East Tick Borne Encephalitis Market

29. Africa Tick Borne Encephalitis Market

30. Tick Borne Encephalitis Market Competitive Landscape And Company Profiles

31. Tick Borne Encephalitis Market Other Major And Innovative Companies

32. Global Tick Borne Encephalitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tick Borne Encephalitis Market

34. Recent Developments In The Tick Borne Encephalitis Market

35. Tick Borne Encephalitis Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â